Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The interleukin inhibitors market was valued at USD 39.45 Billion in 2025 and is expected to grow at a CAGR of 12.20%, reaching USD 124.73 Billion by 2035. The market growth is driven by growing incidence of inflammatory and autoimmune diseases, increasing R&D investment, and the introduction of novel biologics.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
12.2%
Value in USD Billion
2026-2035
*this image is indicative*
Interleukin inhibitors are referred to as the immunosuppressive agents, which limit the activity of interleukins. Interleukin is a group of cytokines that are synthesized by lymphocytes, macrophages, monocytes, and certain other cells. Their role is to regulate the immune system.
Based on type, the interleukin inhibitors market is divided into:
Based on application, the interleukin inhibitors market is segmented into:
The EMR report looks into the regional interleukin inhibitors markets like
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global interleukin inhibitors market is being driven by the highly effective work of interleukin inhibitors in treating autoimmune disease. The interleukin inhibitors market is aided by the numerous approved interleukin inhibitor molecules for treating autoimmune conditions like rheumatoid arthritis, psoriasis, and Crohn’s disease. Moreover, R&D is in progress over interleukin inhibitor molecules, and clinical trials for late-stage molecules is expected to impact market growth positively. Higher patient adherence to these drugs due to their higher affinity and specificity, as compared to other conventional approved autoimmune therapeutics, is predicted to increase their sales.
The report presents a detailed analysis of the following key players in the global interleukin inhibitors market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the interleukin inhibitors market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global interleukin inhibitors market is projected to grow at a CAGR of 12.20% between 2026 and 2035.
The major drivers of the market include the research and development activities, rise in awareness amongst the consumers and physicians, rise in the prevalence of chronic inflammatory diseases such as psoriasis, arthritis, rise in FDA approvals for novel drugs and therapies, increase in the prevalence of autoimmune diseases, and high adoption of advanced treatment options.
The highly effective work of interleukin inhibitors in treating autoimmune diseases and higher patient adherence are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Based on type, the interleukin inhibitors market is divided into L-17, IL-23, IL-1, IL-5, and IL-6, among others.
The major applications include psoriasis, psoriatic arthritis, rheumatoid arthritis, asthma, and inflammatory bowel disease, among others.
The major players in the industry are Novartis AG, AbbVie Inc, Eli Lilly and Company, Regeneron Pharmaceuticals, Inc., Johnson & Johnson Services, Inc, F. Hoffmann-La Roche Ltd, AstraZeneca, Bausch Health, GlaxoSmithKline plc, and Teva Pharmaceuticals Industries, Ltd., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share